◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Satellos Bioscience Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 1.9M 1.7M 1.8M 1.2M 1.2M
General And Administrative Expense 1.9M 1.7M 1.8M 1.2M 1.2M
Research And Development 4.0M 4.4M 4.5M 3.2M 2.4M
Depreciation And Amortization In Income Statement 2,000 1,000 1,000 8,014 2,000
Other Operating Expenses 106,000 187,000 144,000 143,975 81,000
Operating Expense 6.0M 6.4M 6.5M 4.6M 3.7M
Operating Income -6.0M -6.4M -6.5M -4.6M -3.7M
EBIT -6.0M -6.4M -6.5M -3.3M -3.7M
Interest Expense -- -- -- 0.00 0.00
Interest Expense Non Operating -- -- -- 0.00 0.00
Interest Income 349,000 362,000 393,000 130,749 230,000
Interest Income Non Operating 349,000 362,000 393,000 130,749 230,000
Net Interest Income 349,000 362,000 393,000 130,749 230,000
Other Income Expense -185,000 429,000 8,000 1.1M -3.2M
Special Income Charges 0.00 -- -- 171,815 -2.9M
Gain On Sale Of Security -185,000 429,000 8,000 973,492 -249,000
Pretax Income -5.8M -5.6M -6.1M -3.3M -6.6M
Tax Provision 19,000 32,000 63,000 -- 0.00
Tax Effect Of Unusual Items -27,750 64,350 1,200 0.00 0.00
Net Income From Continuing And Discontinued Operation -5.8M -5.6M -6.1M -3.3M -6.6M
Net Income From Continuing Operation Net Minority Interest -5.8M -5.6M -6.1M -3.3M -6.6M
Net Income Including Noncontrolling Interests -5.8M -5.6M -6.1M -3.3M -6.6M
Net Income Common Stockholders -5.8M -5.6M -6.1M -3.3M -6.6M
Net Income -5.8M -5.6M -6.1M -3.3M -6.6M
EBITDA -6.0M -6.4M -6.5M -3.3M -3.7M
Normalized EBITDA -5.8M -6.8M -6.5M -4.4M -544,000
Reconciled Depreciation 3,000 0.00 1,000 8,014 2,000
Basic EPS -0.36 -0.36 -0.48 -- -0.72
Diluted EPS -0.36 -0.36 -0.48 -- -0.72
Basic Average Shares 13.9M 14.3M 13.8M -- 9.4M
Diluted Average Shares 13.9M 14.3M 13.8M -- 9.4M
Total Unusual Items -185,000 429,000 8,000 1.1M -3.2M
Total Unusual Items Excluding Goodwill -185,000 429,000 8,000 1.1M -3.2M
Tax Rate For Calcs 0.15 0.15 0.15 0.00 0.00
Normalized Income -5.7M -6.0M -6.1M -4.4M -3.5M
Depreciation Amortization Depletion Income Statement 2,000 1,000 1,000 8,014 2,000
Depreciation Income Statement 2,000 1,000 1,000 8,014 2,000
Diluted NI Availto Com Stockholders -5.8M -5.6M -6.1M -3.3M -6.6M
Impairment Of Capital Assets 0.00 -- -- -171,815 2.9M
Net Income Continuous Operations -5.8M -5.6M -6.1M -3.3M -6.6M
Net Non Operating Interest Income Expense 349,000 362,000 393,000 130,749 230,000
Other Gand A 686,000 427,000 529,000 508,595 252,000
Salaries And Wages 1.2M 1.3M 1.3M 672,528 978,000
Total Expenses 6.0M 6.4M 6.5M 4.6M 3.7M
Total Operating Income As Reported -6.0M -6.4M -- -4.6M -3.7M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 19.3M 38.2M 32.7M 40.2M 17.3M
Cash Cash Equivalents And Short Term Investments 34.6M 38.2M 41.2M 48.7M 17.3M
Cash Equivalents 13.1M 28.0M 25.6M 15.7M 11.6M
Cash Financial 6.2M 10.2M 7.1M 24.4M 5.8M
Other Short Term Investments 15.3M 0.00 8.5M 8.5M 0.00
Receivables 205,000 186,000 338,000 436,179 141,368
Prepaid Assets 2.7M 2.7M 2.8M 1.8M 428,546
Current Assets 37.5M 41.1M 44.4M 50.9M 17.9M
Gross PPE -- -- 3,000 3,484 12,583
Net PPE 6,000 5,000 3,000 3,484 12,583
Goodwill And Other Intangible Assets -- 0.00 0.00 0.00 0.00
Investments And Advances -- 0.00 0.00 0.00 0.00
Total Non Current Assets 6,000 5,000 3,000 3,484 12,583
Total Assets 37.5M 41.1M 44.4M 50.9M 17.9M
Accounts Payable 1.4M 1.1M 1.9M 2.1M 1.0M
Payables 1.5M 1.2M 1.9M 2.1M 1.0M
Payables And Accrued Expenses 3.5M 2.8M 2.7M 3.6M 2.7M
Current Accrued Expenses 2.0M 1.6M 751,000 1.5M 1.7M
Current Liabilities 3.5M 2.8M 2.7M 3.6M 2.7M
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 3.5M 2.8M 2.7M 3.6M 2.7M
Common Stock 85.5M 82.5M 78.1M 73.7M 46.1M
Capital Stock 85.5M 82.5M 78.1M 73.7M 46.1M
Additional Paid In Capital 9.3M 8.8M 8.3M 7.2M 5.7M
Retained Earnings -74.7M -68.8M -63.2M -52.7M -51.4M
Gains Losses Not Affecting Retained Earnings -1.7M -1.7M -1.5M -151,199 -8,882
Other Equity Adjustments -1.7M -1.7M -1.5M -151,199 -8,882
Common Stock Equity 34.0M 38.3M 41.7M 47.3M 15.2M
Stockholders Equity 34.0M 38.3M 41.7M 47.3M 15.2M
Total Equity Gross Minority Interest 34.0M 38.3M 41.7M 47.3M 15.2M
Total Capitalization 34.0M 38.3M 41.7M 47.3M 15.2M
Net Tangible Assets 34.0M 38.3M 41.7M 47.3M 15.2M
Tangible Book Value 34.0M 38.3M 41.7M 47.3M 15.2M
Working Capital 34.0M 38.3M 41.7M 47.3M 15.2M
Invested Capital 34.0M 38.3M 41.7M 47.3M 15.2M
Share Issued 15.4M 14.7M 13.8M 13.8M 9.4M
Ordinary Shares Number 15.4M 14.7M 13.8M 13.8M 9.4M
Hedging Assets Current 0.00 0.00 0.00 0.00 0.00
Income Tax Payable 114,000 95,000 63,000 -- --
Other Equity Interest 15.5M 17.6M 20.0M 19.2M 14.9M
Other Properties -- -- 3,000 3,484 12,583
Taxes Receivable 205,000 186,000 338,000 436,179 141,368
Total Tax Payable 114,000 95,000 63,000 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -4.1M -4.8M -7.4M -4.7M -3.2M
Cash Flow From Continuing Operating Activities -4.1M -4.8M -7.4M -4.7M -3.2M
Depreciation And Amortization 3,000 0.00 1,000 8,014 2,000
Depreciation Amortization Depletion 3,000 0.00 1,000 8,014 2,000
Stock Based Compensation 774,000 834,000 642,000 239,191 162,000
Change In Working Capital 803,000 319,000 -1.9M -686,806 322,000
Change In Receivables -18,000 151,000 98,000 -320,099 580,000
Change In Payables And Accrued Expense 790,000 40,000 -886,000 958,671 -181,000
Other Non Cash Items -- -- -- -- -39,000
Capital Expenditure -3,000 -- -- -- -440.89
Purchase Of PPE -3,000 -3,000 0.00 260.26 0.00
Net PPE Purchase And Sale -3,000 -3,000 0.00 260.26 0.00
Purchase Of Investment -15.3M 0.00 0.00 -- -101,000
Sale Of Investment 0.00 8.5M 0.00 17.1M 13.1M
Net Investment Purchase And Sale -15.3M 8.5M 0.00 -8.9M 13.0M
Investing Cash Flow -15.3M 8.5M 0.00 -8.9M 13.0M
Cash Flow From Continuing Investing Activities -15.3M 8.5M 0.00 -8.9M 13.0M
Issuance Of Debt -- -- -- 0.00 0.00
Repayment Of Debt -- -- -- 0.00 --
Net Issuance Payments Of Debt -- -- -- 0.00 0.00
Issuance Of Capital Stock -- -- -- 29.8M 0.00
Net Common Stock Issuance -- -- -- 29.8M 0.00
Financing Cash Flow 700,000 1.4M 2,000 37.1M 170,000
Cash Flow From Continuing Financing Activities 700,000 1.4M 2,000 37.1M 170,000
Effect Of Exchange Rate Changes -155,000 484,000 3,000 276,370 305,000
Changes In Cash -18.8M 5.0M -7.4M 23.5M 9.9M
Beginning Cash Position 38.2M 32.7M 40.1M 17.3M 7.2M
End Cash Position 19.3M 38.2M 32.7M 40.2M 17.4M
Free Cash Flow -4.1M -4.8M -7.4M -4.7M -3.2M
Asset Impairment Charge -- -- -- -171,815 --
Change In Prepaid Assets 31,000 128,000 -1.1M -1.3M -77,000
Common Stock Issuance -- -- -- 29.8M 0.00
Depreciation 3,000 0.00 1,000 8,014 2,000
Gain Loss On Investment Securities -- -- -- -826.90 0.00
Long Term Debt Issuance -- -- -- 0.00 0.00
Long Term Debt Payments -- -- -- 0.00 --
Net Foreign Currency Exchange Gain Loss 115,000 -388,000 -3,000 -442,975 34,000
Net Income From Continuing Operations -5.8M -5.6M -6.1M -3.3M -6.6M
Net Long Term Debt Issuance -- -- -- 0.00 0.00
Operating Gains Losses 115,000 -388,000 -3,000 -443,802 34,000
Proceeds From Stock Option Exercised 700,000 1.4M 2,000 7.3M 170,000
NEWS
Loading news...
TRENDING
Loading...